Overview

Gender

male

Mr. Smith has served as our executive vice president and chief commercial officer since February 2012. Prior to that, Mr. Smith served as our senior vice president, sales, marketing and business development of Horizon Pharma USA since October 1, 2010.
Before joining Horizon Pharma, Mr. Smith served as vice president, global marketing, strategy and business development at Fenwal Inc., a global medical device company formed through a TPG financed spin-off from Baxter. Mr. Smith was responsible for Fenwal's global product portfolio, the company's strategic planning and business development initiatives. During this time, Fenwal launched more than 10 products and reignited growth in its core automation businesses.

Mr. Smith has nearly 18 years of pharmaceutical and biotechnology industry experience, holding a succession of senior management roles in sales, marketing and business development at top 20 pharma companies, including Abbott and Bayer, as well as venture-backed biotechs, including Agouron and Achillion. As a sales and marketing executive, Mr. Smith has either led or been part of more than 12 product launches.
He led both sales and marketing activities for the Virology Franchise at Abbott, including the launch of Kaletra tablets (a critical life-cycle reformulation), where global sales grew to more than $1 billion.
In his business development roles, he has structured licensing deals and joint ventures and managed alliances regionally and globally.
He earned a bachelor's degree in political science from Norwich University.